$MDCX 4 SEC Filings

Filed On	Filing
08 Sep 2026	Form 4: Smith Andrew Alasdair, Chief Operating Officer Received 735,294 shares as a grant or award ($125K) · Granted 125,000 Stock Option (right to buy)
08 Sep 2026	Form 4: Mehmud Faisal, Chief Medical Officer Received 1,470,588 shares as a grant or award ($251K) · Granted 250,000 Stock Option (right to buy)
08 Sep 2026	Form 4: Brennan Edward J., Chief Scientific Officer Received 588,235 shares as a grant or award ($100K) · Granted 100,000 Stock Option (right to buy)
08 Sep 2026	Form 4: Bonner Carolyn F., President and CFO Received 1,470,588 shares as a grant or award ($251K) · Granted 250,000 Stock Option (right to buy)
08 Sep 2026	Form 4: Bokhari Raza, Director Received 2,941,176 shares as a grant or award ($501K) · Granted 500,000 Stock Option (right to buy)
04 Jun 2026	Form 4: Smith Andrew Alasdair, Chief Operating Officer Granted 200,000 Stock Option (right to buy)
04 Jun 2026	Form 4: Rodgers Cathy McMorris, Director Granted 50,000 Stock Option (right to buy)
04 Jun 2026	Form 4: Raju Ajay, Director Granted 50,000 Stock Option (right to buy)
04 Jun 2026	Form 4: Mehmud Faisal, Chief Medical Officer Granted 250,000 Stock Option (right to buy)
04 Jun 2026	Form 4: May Sara R., Director Granted 50,000 Stock Option (right to buy)
04 Jun 2026	Form 4: Mahaffy Patrick J, Director Granted 50,000 Stock Option (right to buy)
04 Jun 2026	Form 4: Kaiser Larry, Director Granted 50,000 Stock Option (right to buy)
04 Jun 2026	Form 4: Fishman Barry, Director Granted 50,000 Stock Option (right to buy)
04 Jun 2026	Form 4: Ciaruffoli Robert J., Director Granted 50,000 Stock Option (right to buy)
04 Jun 2026	Form 4: Brennan Edward J., Chief Scientific Officer Granted 25,000 Stock Option (right to buy)
04 Jun 2026	Form 4: Bonner Carolyn F., President and CFO Granted 250,000 Stock Option (right to buy)
04 Jun 2026	Form 4: Bokhari Raza, Director Granted 500,000 Stock Option (right to buy)
04 Jun 2026	Form 4: Ashton William, Director Granted 50,000 Stock Option (right to buy)
01 Apr 2026	Form 4: Smith Andrew Alasdair, Chief Operating Officer Granted 50,000 Stock Option (right to buy)
01 Apr 2026	Form 4: Rodgers Cathy McMorris, Director Granted 25,000 Stock Option (right to buy)

Comments